Status:

UNKNOWN

The Effect of rTEM in the Prognosis and Severity of Sepsis Induced ARDS

Lead Sponsor:

Southeast University, China

Conditions:

Sepsis

Eligibility:

All Genders

18+ years

Brief Summary

To observe the changes of plasma rTEM levels in patients with sepsis, sepsis induced ARDS, and to explore its clinical significance.

Detailed Description

90 patients will be included in this study. Blood samples from these patients in the first day, the third day, were maintained and tested to detect the change of rTEM level. Severity of illness and su...

Eligibility Criteria

Inclusion

  • Diagnosed as Sepsis 3.0 Patients signing informed consent

Exclusion

  • Pregnant women Patients with tumor、hepatitis、liver cirrhosis、acute myocardial infarction、chronic renal tubular nephritis、interstitial pneumonia、acute pancreatitis、systemic lupus erythenatosus、ulcerative colitis、crohn's disease、HELLP syndrome

Key Trial Info

Start Date :

October 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT06063707

Start Date

October 1 2023

End Date

September 1 2024

Last Update

October 3 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.